Strong Sales Growth and Sales Momentum from Mach7

Highlights:

•  Strong sales growth +24% to $10.9M, accelerated momentum in 2H with sales of $12M
•  Revenue $7.1M, down 22% - Strong eUnity growth offset by revenue timing
•  EBITDA loss $1.2M, down from profit of $2.5M – impacted by the timing of revenue
• Recurring revenue annualized at $10.2M (first-half up 88%), providing 64% coverage of operating expenses
• Strong financial position with $14.4M cash at hand, and no debt
•  Positive 2H21 outlook: new contracts already won will drive 2H21 revenue growth, acquisition synergies to deliver lower expenses, positive EBITDA is forecast

Disc; I Hold

Adventist Health Significantly Expands its Enterprise Imaging Strategy with Mach7

? Adventist Health System licenses Mach7 PACS solution

? Total new contract value A$7.9 million

? The expanded relationship will see Mach7 solutions deployed across 22 hospitals

Disc:I hold